Mark E. McGovern

6.5k total citations · 1 hit paper
121 papers, 4.8k citations indexed

About

Mark E. McGovern is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and General Health Professions. According to data from OpenAlex, Mark E. McGovern has authored 121 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Surgery, 23 papers in Endocrinology, Diabetes and Metabolism and 18 papers in General Health Professions. Recurrent topics in Mark E. McGovern's work include Lipoproteins and Cardiovascular Health (32 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (19 papers) and Health disparities and outcomes (13 papers). Mark E. McGovern is often cited by papers focused on Lipoproteins and Cardiovascular Health (32 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (19 papers) and Health disparities and outcomes (13 papers). Mark E. McGovern collaborates with scholars based in United States, United Kingdom and Canada. Mark E. McGovern's co-authors include Michael Thompson, Curt D. Furberg, Jon Pasher, Krishna M. R. Kallury, John R. Crouse, David J. Nowak, Satoshi Hirabayashi, Robert P. Byington, Paul L. Canner and M. Gene Bond and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Geophysical Research Atmospheres and Journal of the American Statistical Association.

In The Last Decade

Mark E. McGovern

110 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Air pollution removal by urban forests in Canada and its effect on air quality and human health

2017 401 citations Mark E. McGovern et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark E. McGovern United States	34	1.7k	1.0k	754	514	509	121	4.8k
Xi Li China	41	613 0.4×	497 0.5×	1.2k 1.6×	533 1.0×	509 1.0×	446	6.8k
Zhiqiang Wang China	56	1.3k 0.8×	946 0.9×	1.0k 1.4×	281 0.5×	376 0.7×	604	12.8k
Vinod Mishra United States	48	963 0.6×	670 0.6×	202 0.3×	331 0.6×	807 1.6×	167	6.6k
Judith S. Jacobson United States	53	995 0.6×	273 0.3×	526 0.7×	534 1.0×	459 0.9×	192	8.8k
Clark W. Heath United States	40	1.2k 0.7×	855 0.8×	909 1.2×	257 0.5×	2.3k 4.4×	95	11.3k
Clyde B. Schechter United States	48	745 0.4×	818 0.8×	640 0.8×	525 1.0×	721 1.4×	254	8.3k
Mary C. White United States	48	674 0.4×	574 0.6×	113 0.1×	445 0.9×	1.2k 2.3×	222	10.2k
James E. Bennett United States	36	473 0.3×	262 0.3×	316 0.4×	311 0.6×	1.2k 2.4×	137	6.1k
William B. Goggins Hong Kong	50	467 0.3×	353 0.3×	311 0.4×	443 0.9×	2.0k 3.9×	152	7.2k
Lauren A. Wise United States	62	884 0.5×	483 0.5×	402 0.5×	192 0.4×	1.8k 3.5×	454	12.4k

Countries citing papers authored by Mark E. McGovern

Since Specialization

Citations

This map shows the geographic impact of Mark E. McGovern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. McGovern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. McGovern more than expected).

Fields of papers citing papers by Mark E. McGovern

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. McGovern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. McGovern. The network helps show where Mark E. McGovern may publish in the future.

Co-authorship network of co-authors of Mark E. McGovern

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. McGovern. A scholar is included among the top collaborators of Mark E. McGovern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. McGovern. Mark E. McGovern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Treglia, Dan, Joy D. Osofsky, Howard J. Osofsky, et al.. (2025). Supporting Infants, Children, and Families After Caregiver Death: Recognizing and Responding to Childhood Grief in Pediatric Primary Care. Clinical Practice in Pediatric Psychology. 13(4). 409–418.

McGovern, Mark E., et al.. (2025). Minimum Wage Policies and Obstetric Disorders in the U.S.. American Journal of Preventive Medicine. 70(2). 108156–108156.

McGovern, Mark E., et al.. (2025). PROM-ising Progress? Trends in Patient- and Clinician-Reported Outcome Measures in US Food and Drug Administration Orphan Drug Labels. Value in Health. 29(2). 197–205.

Rowland, Neil E., et al.. (2024). Long-term exposure to ambient PM2.5 and population health: evidence from linked census data. Economics & Human Biology. 55. 101417–101417. 2 indexed citations

Newburn, Mary, Jo Anne Bennett, Mark E. McGovern, et al.. (2024). RELAX (REducing Levels of AnXiety): a study protocol for a parallel two-arm randomised controlled trial evaluating a web-based early intervention for pregnant women with high levels of repetitive negative thinking to prevent escalating anxiety during pregnancy and after birth. Trials. 25(1). 709–709.

McGovern, Mark E., et al.. (2023). Neighborhood-level housing affordability and maternal depression. SHILAP Revista de lepidopterología. 3. 100192–100192. 12 indexed citations

Clarke‐Deelder, Emma, Slawa Rokicki, Mark E. McGovern, et al.. (2022). Levels of depression, anxiety, and psychological distress among Ugandan adults during the first wave of the COVID-19 pandemic: cross-sectional evidence from a mobile phone-based population survey. SHILAP Revista de lepidopterología. 9. 274–284. 7 indexed citations

McGovern, Mark E., Slawa Rokicki, & Nancy E. Reichman. (2022). Maternal depression and economic well-being: A quasi-experimental approach. Social Science & Medicine. 305. 115017–115017. 16 indexed citations

Wang, Peng, et al.. (2022). Global Imbalances in Funding Sources for HIV Randomized Control Trials. AIDS Research and Human Retroviruses. 39(2). 53–56.

10.

Boden, William E., Michael G. Miller, Ruth McBride, et al.. (2020). Testosterone concentrations and risk of cardiovascular events in androgen-deficient men with atherosclerotic cardiovascular disease. American Heart Journal. 224. 65–76. 36 indexed citations

11.

Perkins, Jessica M., Rockli Kim, Aditi Krishna, et al.. (2017). Understanding the association between stunting and child development in low- and middle-income countries: Next steps for research and intervention. Social Science & Medicine. 193. 101–109. 123 indexed citations

12.

McGovern, Mark E.. (2016). Progress and the Lack of Progress in Addressing Infant Health and Infant Health Inequalities in Ireland during the 20th Century. Arrow@dit (Dublin Institute of Technology). 45. 117–145. 2 indexed citations

13.

McGovern, Mark E., et al.. (2015). Economics of Non-Communicable Diseases in Indonesia. WU Research. 16 indexed citations

14.

McGovern, Mark E.. (2012). Still Unequal At Birth: Birth Weight, Socioeconomic Status, And Outcomes at Age 9. Economic and social review. 44(1). 53–84. 16 indexed citations

15.

McGovern, Mark E., et al.. (2004). 820-5 Once-daily niacin extended-release/lovastatin combination is effective and safe for treatment of dyslipidemia associated with metabolic syndrome. Journal of the American College of Cardiology. 43(5). A486–A487. 2 indexed citations

16.

Superko, H. Robert, et al.. (2004). Differential effect of two nicotinic acid preparations on low-density lipoprotein subclass distribution in patients classified as low-density lipoprotein pattern A, B, or I. The American Journal of Cardiology. 94(5). 588–594. 27 indexed citations

17.

Bays, Harold, et al.. (2003). Once‐Daily Niacin Extended Release/Lovastatin Combination Tablet Has More Favorable Effects on Lipoprotein Particle Size and Subclass Distribution Than Atorvastatin and Simvastatin. Preventive Cardiology. 6(4). 179–188. 53 indexed citations

18.

Canner, Paul L., Curt D. Furberg, Michael L. Terrin, & Mark E. McGovern. (2003). Niacin decreases myocardial infarction and total mortality in patients with metabolic syndrome: Results from the coronary drug project. Journal of the American College of Cardiology. 41(6). 291–291. 19 indexed citations

19.

McGovern, Mark E., et al.. (2003). Safety of combination therapy with once-daily niacin extended-release/lovastatin in over 4,000 patients participating in the impact of medical subspecialty on patient compliance to treatment study. Journal of the American College of Cardiology. 41(6). 245–245. 2 indexed citations

20.

Bays, Harold, Mark E. McGovern, & Phillip Simmons. (2002). Lipoprotein effects of a new dual component drug (extended-release niacin/lovastatin) compared to starting doses of atorvastatin and simvastatin. Journal of the American College of Cardiology. 39. 245–245. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact